esomeprazole

Poland

Drugs containing this active substance

  • EMANERA

    The medicine is used to treat gastroesophageal reflux disease (heartburn, pain, inflammation), gastric and duodenal ulcer disease (including those caused by Helicobacter pylori bacteria or non-steroidal anti-inflammatory drugs [NSAIDs]), as well as in cases of excessive gastric acid secretion caused by pancreatic tumors.

    Form: capsules, hard, intestinal

    Active substance Dosage
    esomeprazole 21.688 mg

    ATC: A02BC05

    Manufacturer: Krka, d.d., Novo mesto

  • The medicine is used in adults to relieve the symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It helps to reduce pain, swelling, redness, and inflammation.

    Form: tablets, modified release

    Active substance Dosage
    naproxen 500 mg
    esomeprazole 20 mg

    ATC: M01AE52

    Manufacturer: Bausch Health Poland Sp. z o.o.

  • It is used in the treatment of gastroesophageal reflux disease (manifesting as pain, inflammation, and heartburn), gastric ulcers (including those caused by non-steroidal anti-inflammatory drugs (NSAIDs) or Helicobacter pylori bacteria), and in cases of excessive stomach acid caused by a pancreatic adenoma.

    Form: capsules, hard, intestinal

    Active substance Dosage
    esomeprazole 20 mg

    ATC: A02BC05

    Manufacturer: Medinsa (Laboratorios Medicamentos Internacionales S.A.)

  • It is used in the treatment of gastroesophageal reflux disease (manifesting as pain, inflammation, and heartburn), gastric ulcers (including those caused by non-steroidal anti-inflammatory drugs (NSAIDs) or Helicobacter pylori bacteria), and in conditions of excessive stomach acid (e.g., in Zollinger-Ellison syndrome).

    Form: capsules, hard, intestinal

    Active substance Dosage
    esomeprazole 43.38 mg

    ATC: A02BC05

    Manufacturer: Medinsa (Laboratorios Medicamentos Internacionales S.A.)

  • The medicine is used for short-term treatment of conditions where oral administration is not possible. In adults, it helps in the treatment of gastroesophageal reflux disease, gastric ulcers (caused by non-steroidal anti-inflammatory drugs [NSAIDs]), and prevents the recurrence of bleeding after endoscopic ulcer treatment. In children and adolescents (1–18 years), it is used for gastroesophageal reflux disease.

    Form: powder for preparation of solution for injection / infusion

    Active substance Dosage
    esomeprazole 40 mg

    ATC: A02BC05

    Manufacturer: Adamed Pharma S.A., Anfarm Hellas S.A.

  • The medicine is used in adults for the short-term treatment of gastroesophageal reflux symptoms, such as heartburn and acid regurgitation.

    Form: capsules, hard, intestinal

    Active substance Dosage
    esomeprazole 20 mg

    ATC: A02BC05

    Manufacturer: TOWA Pharmaceuticals Europe, S.L.

  • The medicine is used to treat gastroesophageal reflux disease (heartburn, pain, inflammation), gastric or intestinal ulcers (including those caused by Helicobacter pylori bacteria or non-steroidal anti-inflammatory drugs [NSAIDs]), excessive stomach acid (Zollinger-Ellison syndrome), and to prevent rebleeding from ulcers.

    Form: capsules, hard, intestinal

    Active substance Dosage
    esomeprazole 22.25 mg

    ATC: A02BC05

    Manufacturer: Laboratorios Liconsa S.A.

  • The medicine is used to treat gastroesophageal reflux disease (heartburn, pain, inflammation), gastric or intestinal ulcers (including those caused by Helicobacter pylori bacteria or anti-inflammatory drugs/NSAIDs), excessive stomach acid (Zollinger-Ellison syndrome), and to prevent rebleeding from ulcers.

    Form: capsules, hard, intestinal

    Active substance Dosage
    esomeprazole 44.5 mg

    ATC: A02BC05

    Manufacturer: Laboratorios Liconsa S.A.

  • The medicine is used for the short-term treatment of conditions where oral medication cannot be taken. In adults, it helps in the treatment of gastroesophageal reflux disease, gastric ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs), and prevents the recurrence of bleeding after the treatment of gastric or duodenal ulcers. In children and adolescents (1–18 years), it is used in the treatment of gastroesophageal reflux disease.

    Form: powder for preparation of solution for injection / infusion

    Active substance Dosage
    esomeprazole 40 mg

    ATC: A02BC05

    Manufacturer: Sun Pharmaceutical Industries Europe B.V.

  • The medicine is used to treat gastroesophageal reflux disease (manifesting as heartburn, pain, and inflammation), gastric or intestinal ulcer disease (also caused by Helicobacter pylori bacteria or non-steroidal anti-inflammatory drugs [NSAIDs]), as well as in cases of excessive gastric acid secretion caused by a pancreatic tumor.

    Form: capsules, hard, intestinal

    Active substance Dosage
    esomeprazole 20 mg

    ATC: A02BC05

    Manufacturer: TOWA Pharmaceuticals Europe, S.L.

  • The medicine is used for short-term treatment of diseases when the patient cannot take medication orally. In adults, it helps in the treatment of gastroesophageal reflux disease, gastric ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs), and prevents recurrence of bleeding after endoscopy. In children and adolescents (1–18 years), it is used for the treatment of gastroesophageal reflux disease.

    Form: powder for preparation of solution for injection and infusion

    Active substance Dosage
    esomeprazole 40 mg
    sodium esomeprazole 42.5 mg

    ATC: A02BC05

    Manufacturer: Tillomed Malta Limited

  • The medicine is used in adults to relieve symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It helps to reduce pain, swelling, redness, and inflammation.

    Form: tablets, modified release

    Active substance Dosage
    naproxen 500 mg
    esomeprazole 22.3 mg

    ATC: M01AE52

    Manufacturer: Flavine Pharma France Interpharma Services Ltd. Salutas Pharma GmbH

  • The medicine is used to reduce the secretion of hydrochloric acid in the stomach. In adults, it helps in the treatment of gastroesophageal reflux disease (GERD) and gastric ulcers caused by the use of non-steroidal anti-inflammatory drugs (NSAIDs). It may also prevent recurrent bleeding after ulcer treatment. In children and adolescents (1–18 years), it is used in the treatment of gastroesophageal reflux disease.

    Form: powder for preparation of solution for injection / infusion

    Active substance Dosage
    esomeprazole 40 mg

    ATC: A02BC05

    Manufacturer: LABORATORIOS NORMON S.A.

  • The medicine is used to treat gastroesophageal reflux disease (heartburn, pain, inflammation), gastric or duodenal ulcers (including those associated with Helicobacter pylori bacteria), ulcers caused by anti-inflammatory drugs (NSAIDs), and in cases of excessive stomach acid caused by Zollinger-Ellison syndrome.

    Form: capsules, hard, intestinal

    Active substance Dosage
    esomeprazole 43.37 mg

    ATC: A02BC05

    Manufacturer: Ethypharm Ethypharm S.C. Zentiva S.A.

  • The medicine is used to treat gastroesophageal reflux disease (heartburn, pain, inflammation), gastric or duodenal ulcers (including those caused by Helicobacter pylori bacteria or anti-inflammatory drugs/NSAIDs), as well as in cases of excessive stomach acid caused by Zollinger-Ellison syndrome.

    Form: capsules, hard, intestinal

    Active substance Dosage
    esomeprazole 21.69 mg

    ATC: A02BC05

    Manufacturer: Ethypharm Ethypharm S.C. Zentiva S.A.

  • The medicine is used in the treatment of gastroesophageal reflux disease (heartburn, pain, inflammation), gastric ulcers (including those caused by Helicobacter pylori bacteria or anti-inflammatory drugs), excessive stomach acid (Zollinger-Ellison syndrome), and in the prevention of recurrent bleeding.

    Form: capsules, hard, intestinal

    Active substance Dosage
    esomeprazole 21.69 mg

    ATC: A02BC05

    Manufacturer: Polpharma Pharmaceutical Works S.A.

  • The medicine is used for the treatment of, among others, gastroesophageal reflux disease (heartburn, pain, inflammation), gastric ulcers (including those caused by Helicobacter pylori bacteria or anti-inflammatory drugs), excessive stomach acid (Zollinger-Ellison syndrome), and in the prevention of recurrent bleeding.

    Form: capsules, hard, intestinal

    Active substance Dosage
    esomeprazole 43.37 mg

    ATC: A02BC05

    Manufacturer: Polpharma Pharmaceutical Works S.A.

  • Stomezul is used to treat gastroesophageal reflux disease (manifesting, among other things, as heartburn and pain), gastric or duodenal ulcers (caused by Helicobacter pylori bacteria or the use of non-steroidal anti-inflammatory drugs [NSAIDs]), as well as in cases of excessive hydrochloric acid secretion in the stomach (Zollinger-Ellison syndrome).

    Form: tablets, enteric-coated

    Active substance Dosage
    esomeprazole 20 mg

    ATC: A02BC05

    Manufacturer: Lek Pharmaceuticals d.d. Lek Pharmaceuticals d.d. LEK S.A. Novartis Pharmaceutical Manufacturing LLC Salutas Pharma GmbH S.C. Sandoz S.R.L.

  • The medicine is used to treat gastroesophageal reflux disease (manifesting as pain, inflammation, and heartburn), gastric or duodenal ulcers (caused by Helicobacter pylori bacteria or the use of non-steroidal anti-inflammatory drugs [NSAIDs]), as well as in cases of excessive gastric acid secretion (Zollinger-Ellison syndrome).

    Form: tablets, enteric-coated

    Active substance Dosage
    esomeprazole 40 mg

    ATC: A02BC05

    Manufacturer: Lek Pharmaceuticals d.d. Lek Pharmaceuticals d.d. LEK S.A. Novartis Pharmaceutical Manufacturing LLC Salutas Pharma GmbH S.C. Sandoz S.R.L.

  • The medicine is used to treat gastroesophageal reflux disease (heartburn, pain, inflammation), gastric or duodenal ulcers (including those caused by Helicobacter pylori bacteria or non-steroidal anti-inflammatory drugs [NSAIDs]), excessive acid secretion in Zollinger-Ellison syndrome, and to prevent rebleeding from ulcers.

    Form: tablets, enteric-coated

    Active substance Dosage
    esomeprazole 20.7 mg

    ATC: A02BC05

    Manufacturer: Pharmachemie B.V. Sun Pharmaceutical Industries Europe B.V. Terapia S.A. Teva Czech Industries s.r.o. Teva Pharma B.V. Teva Pharmaceutical Works Private Limited Company

  • The medicine is used for the treatment of, among others, gastroesophageal reflux disease (heartburn, pain, inflammation), gastric or duodenal ulcers (including those caused by Helicobacter pylori bacteria or non-steroidal anti-inflammatory drugs [NSAIDs]), excess stomach acid (Zollinger-Ellison syndrome), and in the prevention of recurrent ulcer bleeding.

    Form: tablets, enteric-coated

    Active substance Dosage
    esomeprazole 41.4 mg

    ATC: A02BC05

    Manufacturer: Pharmachemie B.V. Terapia S.A. Teva Czech Industries s.r.o. Teva Pharma B.V. TEVA Pharmaceutical Works Pvt. Ltd.